During the past decade, Holy Name Hospital; Institute For Clinical Research conducted 3 clinical trials. In the 10-year time frame, 3 clinical trials started and 2 clinical trials were completed, i.e. on average, 66.7% percent of trials that started reached the finish line to date. In the past 5 years, 2 clinical trials started and 1 clinical trials were completed. i.e. 50% of trials that started reached the finish line.

In terms of collaborators to trials, out of the total clinical trials conducted in "Holy Name Hospital; Institute For Clinical Research" #1 collaborator was "Sucampo Pharmaceuticals, Inc." with 1 trials as a collaborator. Other collaborators include -1 different institutions and companies that were collaborators in the rest 1 trials.

According to Clinical.Site data, the most researched conditions in "Holy Name Hospital; Institute For Clinical Research" are "Multiple Sclerosis, Primary Progressive" (1 trials), "Multiple Sclerosis, Relapsing-Remitting" (1 trials), "Opioid-Induced Bowel Dysfunction" (1 trials), "Relapsing Multiple Sclerosis" (1 trials) and "Skin Infections" (1 trials). Many other conditions were trialed in "Holy Name Hospital; Institute For Clinical Research" in a lesser frequency.

Most popular intervention types in "Holy Name Hospital; Institute For Clinical Research" are "Drug" (5 trials). Other intervention types were less common.

The name of intervention was led by "Fenebrutinib" (2 trials), "Ocrelizumab" (2 trials), "Placebo" (2 trials), "Lubiprostone" (1 trials) and "PZ-601" (1 trials). Other intervention names were less common.

The vast majority of trials in "Holy Name Hospital; Institute For Clinical Research" are 5 trials for "All" genders.

Currently, there are NaN active trials in "Holy Name Hospital; Institute For Clinical Research". undefined are not yet recruiting, 2 are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 3 completed trials in Holy Name Hospital; Institute For Clinical Research, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Holy Name Hospital; Institute For Clinical Research, 0 "Phase 1" clinical trials were conducted, 1 "Phase 2" clinical trials and 4 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".